An international consortium of multidisciplinary researchers and specialists has developed a new method to counter the problem of COVID-19 vaccine falsification.

Professor Philippe Guérin, IDDO and WWARN’s Director, has been awarded the Bailey K. Ashford Medal for his “distinguished” work in tropical medicine.

Join IDDO and WWARN’s researchers at this year’s ASTMH - the 72nd annual meeting in Chicago, USA, where we will be presenting on Visceral Leishmaniasis, malaria, and medicine quality across symposia, oral presentations and posters.

Analysis of data from more than 6,800 patients located across 16 countries has supported the need to increase the dose of the antimalarial drug, primaquine, in malaria endemic countries.

A new viewpoint calling for the standardisation of antibiotics appearance and better information around usage, has been published in The Lancet Global Health.

A research letter published in The Lancet has emphasised the critical need for equity in the allocation of research funding, especially in the context of epidemic response efforts. The letter, ‘Pandemics move faster than funders’ is authored by the members of the COVID-19 Clinical Research Coalition...

The second annual FORESFA meeting, held in Edinburgh, stimulated discussion on forensic investigations of falsified medicines and engagement with potential implementers.

A new WWARN study, which looked at the variability in white blood cell (WBC) count in patients with uncomplicated malaria, found that using the assumed value of WBC in the calculation of parasite density led to a significant underestimation of parasite count for children and potentially sub-optimal ...

The Medicine Quality Research Group took part in an in-person workshop on ‘good laboratory practices’ to support capacity-building and networking for medicines regulators from different countries.

A global collaboration of the visceral leishmaniasis (VL) community has developed freely available, annotated case report forms (CRF) to accelerate research both into uncomplicated VL and specifically for patients with HIV-VL co-infection. The CRFs allow the collection of research-related data in a ...

While 17 countries have now achieved trachoma elimination status, there is still work to be done, with trachoma responsible for the blindness or visual impairment of about 1.9 million people worldwide. Collaborators are being invited to join a new research project aimed at assessing the drivers for ...

A new WWARN study involving a collaboration of 107 researchers has provided unique insights in the epidemiology of submicroscopic malaria in pregnancy.

The latest WWARN newsletter is out now. Read more about our part in a new consortium tackling malaria drug resistance in South-East Africa, which is led by Professor Karen Barnes, of the University of Cape Town.

We are very sad to share news of the death of Professor Dominic Kwiatkowski. He was the Director of the Centre for Genomics and Global Health, and held a joint position as MRC Clinical Research Professor at Oxford University, and as a Principal Investigator at the Wellcome Trust Sanger Institute.

A new study suggests that, although there is sparse evidence, substandard and falsified (SF*) antiretrovirals occur and enhanced surveillance is needed.

Matt Brack, IDDO’s Senior Programme Manager, recently presented on our equitable approach to data collaborations in global health research at the Consortium of Universities for Global Health Conference (CUGH) in Washington, DC.

Last month, experts in medicine quality and substandard and falsified (SF) medicines gathered in Oxford for an informal one-day meeting following the workshop ‘The relationship between substandard and falsified antimicrobials and antimicrobial resistance and patient outcomes’.

A new consortium MARC SE-Africa (Mitigating Antimalarial Resistance Consortium in Southern and East Africa) launches today, responding to a growing crisis in malaria, one of the greatest infectious challenges facing Africa.

The Infectious Diseases Data Observatory (IDDO) is delighted to announce that Dr James Watson has been appointed as the new Associate Director from March 2023.